Interstitial pneumonitis and lung fibrosis during adjuvant treatment of melanoma with interferon alpha according to the Kirkwood schedule

Dermatology. 2005;210(3):247-9. doi: 10.1159/000083796.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects*
  • Diabetes Mellitus, Type 2
  • Diagnosis, Differential
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Lung Diseases, Interstitial / chemically induced
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / diagnostic imaging
  • Lung Diseases, Interstitial / pathology
  • Melanoma / drug therapy*
  • Parkinson Disease
  • Pulmonary Fibrosis / chemically induced
  • Pulmonary Fibrosis / diagnosis
  • Pulmonary Fibrosis / diagnostic imaging
  • Pulmonary Fibrosis / pathology
  • Recombinant Proteins
  • Skin Neoplasms / drug therapy*
  • Tomography, X-Ray Computed
  • Tuberculosis, Pulmonary

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins